ZA899176B - Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment - Google Patents

Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment

Info

Publication number
ZA899176B
ZA899176B ZA899176A ZA899176A ZA899176B ZA 899176 B ZA899176 B ZA 899176B ZA 899176 A ZA899176 A ZA 899176A ZA 899176 A ZA899176 A ZA 899176A ZA 899176 B ZA899176 B ZA 899176B
Authority
ZA
South Africa
Prior art keywords
treatment
carnitine
glaucoma
acetyl
pharmaceutical compositions
Prior art date
Application number
ZA899176A
Other languages
English (en)
Inventor
Claudio Cavazza
Cavazza Claudio
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ZA899176B publication Critical patent/ZA899176B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA899176A 1988-12-01 1989-11-30 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment ZA899176B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848614A IT1224795B (it) 1988-12-01 1988-12-01 Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento

Publications (1)

Publication Number Publication Date
ZA899176B true ZA899176B (en) 1990-09-26

Family

ID=11267644

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899176A ZA899176B (en) 1988-12-01 1989-11-30 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment

Country Status (13)

Country Link
US (2) US5145871A (ja)
EP (1) EP0446268B1 (ja)
JP (1) JP2763400B2 (ja)
KR (1) KR950004885B1 (ja)
AU (1) AU628116B2 (ja)
CA (1) CA2004239C (ja)
DK (1) DK175891B1 (ja)
ES (1) ES2040106T3 (ja)
GR (1) GR1000465B (ja)
IE (1) IE62568B1 (ja)
IT (1) IT1224795B (ja)
WO (1) WO1990006111A1 (ja)
ZA (1) ZA899176B (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
DK0951909T4 (da) 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
AU2001237939A1 (en) * 2000-02-08 2001-08-20 Gulgun Tezel Methods for treating glaucoma
CZ2004150A3 (cs) * 2001-07-06 2004-09-15 Teva Pharmaceutical Industries Ltd. Způsob přípravy derivátů 7-amino syn 3,5-dihydroxyheptanové kyseliny přes deriváty 6-kyan syn-3,5-dihydroxyheptanové kyseliny
WO2003055443A2 (en) 2001-10-31 2003-07-10 Alcon, Inc. Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
ITRM20020492A1 (it) * 2002-10-01 2004-04-02 Sigma Tau Ind Farmaceuti Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
EP1594439A2 (en) 2003-02-13 2005-11-16 Albert Einstein College Of Medicine Of Yeshiva University REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US6951658B1 (en) 2003-07-08 2005-10-04 Pearson Research & Development Limited Emu-based compositions for mental well-being and method of use
US7718697B2 (en) * 2003-12-17 2010-05-18 Alcon, Inc. Method for treating glaucoma comprising administering α-lipoic acid
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EP2363126A1 (en) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
WO2012069221A1 (en) 2010-11-22 2012-05-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutical method for the treatment of the leber optic
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
IN2014CN04809A (ja) 2011-12-07 2015-09-18 Allergan Inc
EP2783695A1 (en) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
EP3223794A1 (en) 2014-11-25 2017-10-04 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
IT202100020729A1 (it) 2021-08-02 2023-02-02 Univ Degli Studi Di Napoli Federico Ii Preparazione combinata per il trattamento della malattia di Pompe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262864A (en) * 1982-09-17 1989-11-14 Clarence D. Cone Method for producing oncolysis

Also Published As

Publication number Publication date
IE893840L (en) 1990-06-01
IE62568B1 (en) 1995-02-08
IT8848614A0 (it) 1988-12-01
US5145871A (en) 1992-09-08
KR920702216A (ko) 1992-09-03
AU4658489A (en) 1990-06-26
JP2763400B2 (ja) 1998-06-11
CA2004239A1 (en) 1990-06-01
JPH04502161A (ja) 1992-04-16
EP0446268A1 (en) 1991-09-18
ES2040106T3 (es) 1993-10-01
IT1224795B (it) 1990-10-24
DK175891B1 (da) 2005-05-30
DK95091A (da) 1991-05-21
GR890100797A (en) 1991-03-15
AU628116B2 (en) 1992-09-10
US5432199A (en) 1995-07-11
KR950004885B1 (ko) 1995-05-15
CA2004239C (en) 1999-11-09
WO1990006111A1 (en) 1990-06-14
DK95091D0 (da) 1991-05-21
EP0446268B1 (en) 1993-04-14
GR1000465B (el) 1992-07-30

Similar Documents

Publication Publication Date Title
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
GB2221390B (en) Niacin-containing composition and its therapeutic use
AU3590489A (en) Use of gamma-hydroxybutyric acid salts in the treatment of alcoholism and pharmaceutical compositions thereof
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
IL114586A (en) Droloxifene for use in the treatment of cardiovascular diseases and pharmaceutical compositions comprising same
IL91069A (en) Intravenous pharmaceutical compositions and their preparation
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
AU4342989A (en) Mercapto-acylamino acids useful in the treatment of cardiovascular disorders and as analgesics
IT8848558A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
AU626033B2 (en) Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
GB2294637B (en) Therapeutic compositions and methods of use
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
AU2742395A (en) Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
HU896326D0 (en) Process for the preparation of aminoacid derivatives and pharmaceutical compositions thereof
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances